Informational Tool for Smoking Cessation in COPD Patients (IMPACT-BPCO)
August 7, 2025 updated by: Hopital Nord Franche-Comte
Implementation and Impact Study of an Informational Tool for Smoking Cessation in COPD Patients
Chronic obstructive pulmonary disease (COPD) is a lung disease that affects nearly 8% of the adult population and causes 18,000 deaths per year in France.
The most frequent cause of this pathology is smoking.
COPD patients who stop smoking have a better quality of life, a marked a significant slowdown in disease progression and an increased life expectancy.
Investigators propose to carry out a quantitative study among patients smokers suffering from COPD, by setting up a tool in the form of an motivational intervention specific to this population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
implementing a tool in the form of an informational intervention with a specific motivational intervention
Study Type
Observational
Enrollment (Actual)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trevenans, France, 90400
- Hôpital Nord Franche-Comté
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
People suffering from chronic obstructive pulmonary disease (COPD) stage 2/3
Description
Inclusion Criteria:
- People suffering from chronic obstructive pulmonary disease (COPD) stage 2/3
- People treated at HNFC
- Smokers
Exclusion Criteria:
- People with cognitive disorders compromising comprehension and completion of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
informational intervention
|
informational intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
motivational effectiveness
Time Frame: 60 days
|
Motivation to stop smoking (QMAT test)
|
60 days
|
|
motivational effectiveness
Time Frame: 60 days
|
Anxio-depressive state (HAD scale)
|
60 days
|
|
motivational effectiveness
Time Frame: 60 days
|
Degree of dependence (Fagerström test)
|
60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 14, 2025
Primary Completion (Actual)
May 9, 2025
Study Completion (Actual)
May 9, 2025
Study Registration Dates
First Submitted
February 25, 2025
First Submitted That Met QC Criteria
March 10, 2025
First Posted (Actual)
March 12, 2025
Study Record Updates
Last Update Posted (Actual)
August 8, 2025
Last Update Submitted That Met QC Criteria
August 7, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-11-IMPACT BPCO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.